Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2012
08/30/2012US20120219539 Method for Preparing Raw Material for Functional Foods from Barley or Wheat Seeds
08/30/2012US20120219527 Compositions for reducing gastro-intestinal methanogenesis in ruminants
08/30/2012US20120219526 Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof
08/30/2012US20120219525 Stable thickener formulations
08/30/2012US20120219510 Natural extract from whole banana fruit (musa spp)
08/30/2012US20120219498 Compositions and methods for inducing angiogenesis
08/30/2012CA2827923A1 Fc.gamma.riib-specific fc antibody
08/29/2012EP2492269A1 Aminothiazole derivative
08/29/2012EP2491050A2 Glycoside derivative and uses thereof
08/29/2012EP2491040A2 Method of preparing sitagliptin and intermediates used therein
08/29/2012EP2491029A1 Glycoside derivatives and uses thereof
08/29/2012EP2490719A2 Methods of using anti-cd3 antibodies to prevent weight gain
08/29/2012EP2490705A1 Use of extracts from salonum glaucophyllum for treating bone metabolism disorders and kidney disorders
08/29/2012EP2490699A1 Oral delivery of therapeutically effective lna oligonucleotides
08/29/2012EP2490696A1 Methods and pharmaceutical compositions for the treatment of disorders of glucose homeostasis
08/29/2012EP2490695A1 Method of preventing type 1 diabetes
08/29/2012EP2490686A1 The new application of 2-pyrrolidone derivatives
08/29/2012EP2490678A1 Coated capsules and tablets of a fatty acid oil mixture
08/29/2012EP2490533A1 Novel compositions for preventing and/or treating lysosomal storage disorders
08/29/2012CN1841066B Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
08/29/2012CN102652139A Pcsk9 antagonists
08/29/2012CN102652129A Amino oxazine derivatives
08/29/2012CN102648977A Application of follistatin-related protein 1 in adjusting Na, K-ATPase activity
08/29/2012CN102648971A Traditional Chinese medicinal composition for treating hyperlipidemia caused by internal obstruction of phlegm and dampness
08/29/2012CN102648959A Royal jelly enteric preparation and preparation method thereof
08/29/2012CN102648949A Health care product for improving blood fat
08/29/2012CN102648941A New application for antioxidation action of cortex dictamni extract
08/29/2012CN102648935A Method for extracting cedrela sinensis total polyphenol
08/29/2012CN102648932A Method for extracting alfalfa saponin
08/29/2012CN102648923A Amaroucium constellatum lipophilic extract
08/29/2012CN102648920A Liquid preparation containing polygluosan
08/29/2012CN102648919A New application of glucomannan
08/29/2012CN102648747A Composition with fat-reducing function and preparation method of same
08/29/2012CN102260291B Riboflavin sodium phosphate crystalline compound and preparation method thereof
08/29/2012CN102258709B Traditional Chinese medicine preparation for treating diabetic retinopathy, and preparation method thereof
08/29/2012CN102218081B Manufacturing method of crocodile bone powder
08/29/2012CN102205088B Chinese medicinal capsules for treating fatty liver
08/29/2012CN102145121B Chinese medical preparation assisting to adjusting blood sugar
08/29/2012CN102145087B Traditional Chinese medicine preparation for regulating blood fat
08/29/2012CN102138910B Atorvastatin calcium tablets and preparation method thereof
08/29/2012CN102048991B Sugar-reducing comfort pill and preparation method thereof
08/29/2012CN101955477B 2-cyclopropyl-4-substituted thiophenyl quinoline compounds as well as intermediate, preparation method and application thereof
08/29/2012CN101947206B Method for preparing recombinant pancreotropic hormone secretion peptide medicament microspheres
08/29/2012CN101919584B Slimming functional electronic cigarette liquid
08/29/2012CN101909619B Composition comprising sesamin component and quercetin glycoside
08/29/2012CN101857642B Polysaccharide derivative and vanadium complex application thereof
08/29/2012CN101791296B Orlistat tablets and preparation method thereof
08/29/2012CN101732259B Chitosan micron particle as well as preparation method and application thereof
08/29/2012CN101709251B Bee milk costus and amomum wine
08/29/2012CN101613267B Dihydroxyoleic acid, preparation method and application thereof
08/29/2012CN101574391B Prevention and treatment of diseases induced by microcirculation disturbance with compatible combination of total salvianolic acid and panax notoginoside
08/29/2012CN101538238B Polymorphs of atorvastatin tert.-butylester and use as intermediates for the preparation of atorvastatin
08/29/2012CN101496790B Acarbose chewable tablet
08/29/2012CN101390623B Qingshen five-flavor dried noodle and production method thereof
08/29/2012CN101380049B Black tea extract rich in statins and preparation technique and use thereof
08/29/2012CN101182562B Method for producing extracellular polysaccharide through golden fungus liquid fermentation and uses thereof
08/29/2012CN101116671B Spacing mutagenicity high-yield highly-effective strain and use thereof
08/29/2012CN101108878B Glp-1 analogues
08/28/2012US8252948 Fat composition
08/28/2012US8252929 8-carboxamido-2,6-methano-3-benzazocines
08/28/2012US8252818 Nicotinamide derivatives useful as P38 inhibitors
08/28/2012US8252815 Nociceptin analogs
08/28/2012US8252791 Purine compounds as cannabinoid receptor blockers
08/28/2012US8252781 1,2-diazetidin-3-one derivatives and drugs containing same
08/28/2012US8252751 Organic compounds
08/28/2012US8252739 Albumin fusion proteins
08/28/2012US8252537 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene; point mutations; solid phase synthesis; immunoassay; vectors; primers; host cells; antibodies; kits; gene therapy
08/28/2012US8252322 Delivery system with increased bioavailability
08/28/2012CA2651378C Fxr agonists
08/28/2012CA2649619C Whey protein-containing granules and method of producing the same
08/28/2012CA2581666C Process for producing concentrate of unsaturated fatty acid
08/28/2012CA2566970C Use of furan alkyl for preparing an antidiabetic drug
08/28/2012CA2534493C Butenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and use for the treatment of dyslipidaemia, atherosclerosis and diabetes
08/28/2012CA2479414C Inhibition of the .beta.3 subunit of l-type ca2+ channels
08/28/2012CA2454073C Mutations in ion channels
08/28/2012CA2409930C Use of zoledronate for the manufacture of a medicament for the treatment of bone metabolism diseases
08/28/2012CA2387805C Nucleic acids encoding endotheliases, endotheliases and uses thereof
08/23/2012WO2012112946A1 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
08/23/2012WO2012112626A2 Compositions, devices and methods of use thereof for the treatment of cancers
08/23/2012WO2012112520A1 A formulations comprising omega 3 fatty acids and an anti obesity agent for the reduction of body weight in cardiovascular disease patients (cvd) and diabetics
08/23/2012WO2012111995A1 Oxime derivatives as gpr119 agonists
08/23/2012WO2012111795A1 Ameliorating agent for lifestyle-related diseases containing water extract of colored onion
08/23/2012WO2012111643A1 Adiponectin production promoter, and medicinal composition, food, drink and feed containing adiponectin production promoter
08/23/2012WO2012110599A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation
08/23/2012WO2012110017A1 Dietetic or pharmaceutical preparation containing tartary buckwheat
08/23/2012WO2012109996A1 Aryl glycoside compound, preparation method and use thereof
08/23/2012WO2012094462A3 Heterocyclic compounds for the inhibition of pask
08/23/2012WO2012069420A3 Calcium-sensing receptor-active compounds
08/23/2012US20120214872 Bile acid or bile salt fatty acid conjugates
08/23/2012US20120214869 Novel ligand activators of the rar receptors and pharmaceutical/cosmetic applications thereof
08/23/2012US20120214866 Treatment with cytokines
08/23/2012US20120214858 Imidamide sphingosine kinase inhibitors
08/23/2012US20120214854 Carboxy oxazole or thiazole compounds as dgat- 1 inhibitors useful for the treatment of obesity
08/23/2012US20120214849 Dual-acting antihypertensive agents
08/23/2012US20120214847 2-[1-PHENYL-5-HYDROXY-4a-SUBSTITUTED-HEXAHYDROCYCLOPENTA[F]INDAZOL-5-YL]ETHYL PHENYL DERIVATIVES AS GLUCOCORTICOID RECEPTOR LIGANDS
08/23/2012US20120214846 Hexahydrocyclopentyl[f]indazole pyridyl ethanols and derivatives thereof as selective glucocorticoid receptor modulators
08/23/2012US20120214841 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
08/23/2012US20120214840 Indolizine inhibitors of 5-lipoxygenase
08/23/2012US20120214837 Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (pde10a)
08/23/2012US20120214827 Anhydrous Crystalline Forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
1 ... 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 ... 1298